1. Synopsis: Special Issue on “Disruption of signaling homeostasis induced crosstalk in the carcinogenesis paradigmEpistemology of the origin of cancer”
   Björn L.D.M. Brücher et al, 2019, 4open CrossRef
2. Breast Cancer with Increased Drug Resistance, Invasion Ability, and Cancer Stem Cell Properties through Metabolism Reprogramming
   Kian-Hwee Chong et al, 2022, International Journal of Molecular Sciences CrossRef
3. Prognostic value of Maspin protein level in patients with triple negative breast cancer
   Renan Gomes do Nascimento et al, 2024, Scientific Reports CrossRef
4. Circular RNAs as Potential Biomarkers in Breast Cancer
   Fatima Domenica Elisa De Palma et al, 2022, Biomedicines CrossRef
5. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
   Elizabeth Varghese et al, 2020, Cancers CrossRef
6. Breast Cancer and Next-Generation Sequencing: Towards Clinical Relevance and Future
   Michele Araújo Pereira et al, 2022, Breast Cancer: From Bench to Personalized Medicine CrossRef
7. Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells
   Qing-Ming Wang et al, 2018, Cancer Immunology Research CrossRef
8. Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management
   Sylvain Loric et al, 2023, International Journal of Molecular Sciences CrossRef
9. Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis
   Yunxiao Liu et al, 2018, International Journal of Oncology CrossRef
10. Advances in the Molecular Taxonomy of Breast Cancer
    Luiz Paulo Guido et al, 2020, Archives of Medical Research CrossRef
11. Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition
    Philip Chiu‐Tsun Tang et al, 2022, Advanced Science CrossRef
12. Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
    Yinnan Chen et al, 2018, Advanced Science CrossRef
13. PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
    Caroline Spasojevic et al, 2018, Oncotarget CrossRef
14. Cell‐specific biomarkers and targeted biopharmaceuticals for breast cancer treatment
    Mei Liu et al, 2016, Cell Proliferation CrossRef
15. Discovery of 1-(3-aryl-4-chlorophenyl)-3-( p -aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings
    Wenlu Li et al, 2017, European Journal of Medicinal Chemistry CrossRef
16. Cell growth analysis and nucleotide excision repair modulation in breast cancer cells submitted to a protocol using doxorubicin and paclitaxel
    Franciele Faccio Busatto et al, 2021, Life Sciences CrossRef
17. The diagnostic value of DNA repair gene in breast cancer metastasis
    Yongxin Yang et al, 2020, Scientific Reports CrossRef
18. Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism
    Xiujun Li et al, 2024, Frontiers in Immunology CrossRef
19. Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy
    Sandra Medel et al, 2017, European Polymer Journal CrossRef